Latest News and Press Releases
Want to stay updated on the latest news?
-
Second quarter sales were $171.2 million, up 3% sequentially and down 9% vs. Q2 2023Net income was $6.3 million, while net income attributable to DMC was $4.0 millionAdjusted net income attributable...
-
Visiongain has published a new report entitled Retinal Gene Therapy Market Report 2024-2034: Forecasts by Approach (Gene Replacement, Gene Silencing, Gene Editing, Modifier Gene Therapy, Others), by...
-
NEWARK, Del, July 23, 2024 (GLOBE NEWSWIRE) -- The global magnesium carbonate mineral industry is set to expand at a CAGR of 4.8% and reach a valuation of USD 386.7 million by 2034. The magnesium...
-
BROOMFIELD, Colo., July 11, 2024 (GLOBE NEWSWIRE) -- DMC Global Inc. (Nasdaq: BOOM) will announce its 2024 second quarter financial results after the stock market closes on Thursday, August 1, 2024....
-
NEWARK, Del, July 02, 2024 (GLOBE NEWSWIRE) -- The diabetic food market value is expected to rise from USD 12,000 million in 2024 to USD 17,891 million by 2034. Global demand is forecast to surge at...
-
BROOMFIELD, Colo., June 25, 2024 (GLOBE NEWSWIRE) -- DMC Global Inc. (Nasdaq: BOOM) today announced that its board of directors has elected Simon Bates as an independent director. Mr. Bates...
-
Chicago, June 20, 2024 (GLOBE NEWSWIRE) -- The Dimethyl Carbonate Market is projected to grow from USD 1.1 billion in 2023 to USD 1.9 billion by 2028, at a CAGR of 12.7% in terms of value, as per...
-
BROOMFIELD, Colo., June 14, 2024 (GLOBE NEWSWIRE) -- DMC Global Inc. (Nasdaq: BOOM) (“DMC” or the “Company”) today commented on Steel Connect’s recent unsolicited proposal (the “Proposal”). DMC’s...
-
75% of patients in the rivaroxaban arm voluntarily switched from the once-daily oral anticoagulant to once-monthly abelacimab Landmark AZALEA-TIMI 71 Study previously stopped early due to an...
-
BROOMFIELD, Colo., June 06, 2024 (GLOBE NEWSWIRE) -- DMC Global Inc. (Nasdaq: BOOM) today announced its board of directors (the “Board”) has unanimously adopted a limited-duration Stockholder...